Cerenome, Inc. (CNSY) vs Lisata Therapeutics, Inc. (LSTA)
A side-by-side comparison of Cerenome, Inc. and Lisata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSY
Cerenome, Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 11:02 AM EDT
LSTA
Lisata Therapeutics, Inc.
$1.20HealthcareDelayed quote: Oct 6, 2026, 11:04 AM EDT
Total return — CNSY vs LSTA
growth of $100 · dividends reinvested · last 1yCNSY -61.5% (-61.5%/yr)LSTA -62.9% (-62.9%/yr)CNSY compounded faster over this window
CNSY LSTA
CNSY vs LSTA: by the numbers
- •LSTA is the larger company ($11M vs $11M market cap).
- •Both run net losses; CNSY's is the smaller (-620.70% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | CNSY | LSTA |
|---|---|---|
| P/S ratio | 2.57 | 109.28 |
| P/B ratio | 1.98 | 1.33 |
Profitability
| Metric | CNSY | LSTA |
|---|---|---|
| Gross margin | 89.58% | 14.12% |
| Operating margin | -293.46% | -10711.18% |
| Net margin | -620.70% | -14621.00% |
| ROE | -477.54% | -177.35% |
| ROIC | -479.39% | -204.32% |
Growth (annualized)
| Metric | CNSY | LSTA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -40.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.